» Articles » PMID: 39062795

Impact of Maternal Pre-Pregnancy Underweight on Cord Blood Metabolome: An Analysis of the Population-Based Survey of Neonates in Pomerania (SNiP)

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jul 27
PMID 39062795
Authors
Affiliations
Soon will be listed here.
Abstract

Intrauterine growth restriction leads to an altered lipid and amino acid profile in the cord blood at the end of pregnancy. Pre-pregnancy underweight is an early risk factor for impaired fetal growth. The aim of this study was to investigate whether a pre-pregnancy body mass index (ppBMI) of <18.5 kg/m, as early as at the beginning of pregnancy, is associated with changes in the umbilical cord metabolome. In a sample of the Survey of Neonates in Pomerania (SNIP) birth cohort, the cord blood metabolome of n = 240 newborns of mothers with a ppBMI of <18.5 kg/m with n = 208 controls (ppBMI of 18.5-24.9 kg/m) was measured by NMR spectrometry. A maternal ppBMI of <18.5 kg/m was associated with increased concentrations of HDL4 cholesterol, HDL4 phospholipids, VLDL5 cholesterol, HDL 2, and HDL4 Apo-A1, as well as decreased VLDL triglycerides and HDL2 free cholesterol. A ppBMI of <18.5 kg/m combined with poor intrauterine growth (a gestational weight gain (GWG) < 25th percentile) was associated with decreased concentrations of total cholesterol; cholesterol transporting lipoproteins (LDL4, LDL6, LDL free cholesterol, and HDL2 free cholesterol); LDL4 Apo-B; total Apo-A2; and HDL3 Apo-A2. In conclusion, maternal underweight at the beginning of pregnancy already results in metabolic changes in the lipid profile in the cord blood, but the pattern changes when poor GWG is followed by pre-pregnancy underweight.

References
1.
van Lee L, Crozier S, Aris I, Tint M, Sadananthan S, Michael N . Prospective associations of maternal choline status with offspring body composition in the first 5 years of life in two large mother-offspring cohorts: the Southampton Women's Survey cohort and the Growing Up in Singapore Towards healthy Outcomes.... Int J Epidemiol. 2019; 48(2):433-444. PMC: 6751083. DOI: 10.1093/ije/dyy291. View

2.
Anastasius M, Kockx M, Jessup W, Sullivan D, Rye K, Kritharides L . Cholesterol efflux capacity: An introduction for clinicians. Am Heart J. 2016; 180:54-63. DOI: 10.1016/j.ahj.2016.07.005. View

3.
Marchlewicz E, Dolinoy D, Tang L, Milewski S, Jones T, Goodrich J . Lipid metabolism is associated with developmental epigenetic programming. Sci Rep. 2016; 6:34857. PMC: 5054359. DOI: 10.1038/srep34857. View

4.
Martyn C, Barker D, Osmond C . Mothers' pelvic size, fetal growth, and death from stroke and coronary heart disease in men in the UK. Lancet. 1996; 348(9037):1264-8. DOI: 10.1016/s0140-6736(96)04257-2. View

5.
Forsen T, Eriksson J, Tuomilehto J, Teramo K, Osmond C, Barker D . Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ. 1997; 315(7112):837-40. PMC: 2127571. DOI: 10.1136/bmj.315.7112.837. View